{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lutz CS"],"funding":["U.S. Department of Energy","Oak Ridge Institute for Science and Education","Centers for Disease Control and Prevention","Intramural CDC HHS"],"pagination":["4219-4230"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12288909"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["39(30)"],"pubmed_abstract":["<h4>Background</h4>During the 2009 influenza A(H1N1)pdm09 pandemic, 77 countries received donated monovalent A(H1N1)pdm09 vaccine through the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. However, 47% did not receive their first shipment until after the first wave of virus circulation, and 8% did not receive their first shipment until after the WHO declared the end of the pandemic. Arguably, these shipments were too late into the pandemic to have a substantial effect on virus transmission or disease burden during the first waves of the pandemic.<h4>Objectives</h4>In order to evaluate the potential benefits of earlier vaccine availability, we estimated the number of illnesses and deaths that could be averted during a 2009-like influenza pandemic under five different vaccine-"],"journal":["Vaccine"],"pubmed_title":["Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries."],"pmcid":["PMC12288909"],"funding_grant_id":["CC999999"],"pubmed_authors":["Bresee JS","Lafond KE","Azziz-Baumgartner E","Biggerstaff M","Reed C","Lutz CS","Porter RM","Rolfes MA"],"additional_accession":[]},"is_claimable":false,"name":"Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.","description":"<h4>Background</h4>During the 2009 influenza A(H1N1)pdm09 pandemic, 77 countries received donated monovalent A(H1N1)pdm09 vaccine through the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. However, 47% did not receive their first shipment until after the first wave of virus circulation, and 8% did not receive their first shipment until after the WHO declared the end of the pandemic. Arguably, these shipments were too late into the pandemic to have a substantial effect on virus transmission or disease burden during the first waves of the pandemic.<h4>Objectives</h4>In order to evaluate the potential benefits of earlier vaccine availability, we estimated the number of illnesses and deaths that could be averted during a 2009-like influenza pandemic under five different vaccine-","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jul","modification":"2026-03-31T10:48:30.431Z","creation":"2025-08-28T03:05:46.633Z"},"accession":"S-EPMC12288909","cross_references":{"pubmed":["34119348"],"doi":["10.1016/j.vaccine.2021.05.006"]}}